Antibody glycosylation in neuroimmune diseases
Open Access
- 25 December 2025
- journal article
- review article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Glycosylation, a critical post-translational modification of proteins, is particularly evident in immunoglobulins (Ig), also known as antibodies, and playsKeywords
This publication has 143 references indexed in Scilit:
- Impact of IgG Fc Glycosylation on Disease Dynamics in Patients With Primary Sjögren DiseaseArthritis & Rheumatology, 2024
- Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic‐Refractory Lyme ArthritisArthritis & Rheumatology, 2023
- What Is Multiple Sclerosis?JAMA, 2022
- IgG Anti–Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross‐Sectional Study Encompassing ~1,500 SamplesArthritis & Rheumatology, 2022
- Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?Muscle & Nerve, 2014
- Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti–aquaporin‐4 immunoglobulin G into therapeutic antibodyAnnals of Neurology, 2012
- Functional analysis of agalactosyl IgG in inflammatory bowel disease patientsInflammatory Bowel Diseases, 2011
- Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serumProteomics, 2007
- Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritisEuropean Journal of Immunology, 2007
- Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co‐expression of heterologous β1, 4‐N‐acetylglucosaminyltransferase III and Golgi α‐mannosidase IIBiotechnology and Bioengineering, 2006